Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1765-2025

Centurion Sterile Weitlaner Retractor, Reorder: 67315 Recall

Centurion Sterile Weitlaner Retractor, Reorder: 67315

FDA recall Class II

Ongoing

FDA lists this Class II recall for Centurion Sterile Weitlaner Retractor, Reorder: 67315. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1765-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 9, 2025
FDA report date
May 21, 2025
Quantity in commerce
2100 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Centurion Sterile Weitlaner Retractor, Reorder: 67315

Affected model & UDI checker

Search the exact identifiers published for Z-1765-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedCenturion Sterile Weitlaner Retractor, Reorder: 67315Check source notice10653160379867
Not specifiedCenturion Sterile Weitlaner Retractor, Reorder: 67315Check source notice00653160379860
FDA code information

UDI/DI 10653160379867 (each) 00653160379860 (case), Lot Numbers: 2020092801, 2020100601, 2021022601, 2021032301, 2021042301, 2021060101, 2021062101, 2021090790, 2022021190, 2022032390, 2022040690, 2022061690, 2022072690, 2022091490, 2023020990, 2023100590, 2023120790, 2024012990, 2024022290, 2024040590, 2024070290, 2024080190, 2024092790, 2025011490.

View the original FDA recall notice

Why was this product recalled?

Three is the potential for the retractors to puncture through the sterile packaging.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did MEDLINE INDUSTRIES, LP - Northfield take?

Medline issued a MEDLINE DEVICE RECALL notice to its consignees on 04/09/2025, The notice explained the issue, potential risk, and requested the following: REQUIRED ACTION: 1.Immediately check your stock for the affected item number(s) and the affected lot number(s) listed within the recall portal. Quarantine all affected product. Upon completion of the below actions, please destroy affected product. 2.Please use the link and the information below to complete your response form. Please list the quantity of affected product you have in inventory on the form. Even if you do not have any affected product in inventory, please complete and submit the response form. Website link: https://recalls.medline.comRecall Reference #: R-25-072Recall Code: RECALL CODE 3.Your account will receive credit once the response form is submitted. 4.If you are a distributor, or have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication. Please request that customers destroy any affected product. You should include your customers quantities on your response form. If you have any questions, contact the Recall Department at 866-359-1704 or [email protected].

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology